Your browser doesn't support javascript.
loading
Long-term single-cell passaging of human iPSC fully supports pluripotency and high-efficient trilineage differentiation capacity.
Cruvinel, Estela; Ogusuku, Isabella; Cerioni, Rosanna; Rodrigues, Sirlene; Gonçalves, Jéssica; Góes, Maria Elisa; Alvim, Juliana Morais; Silva, Anderson Carlos; Lino, Vanesca de Souza; Boccardo, Enrique; Goulart, Ernesto; Pereira, Alexandre; Dariolli, Rafael; Valadares, Marcos; Biagi, Diogo.
Afiliação
  • Cruvinel E; PluriCell Biotech, São Paulo, Brazil.
  • Ogusuku I; PluriCell Biotech, São Paulo, Brazil.
  • Cerioni R; PluriCell Biotech, São Paulo, Brazil.
  • Rodrigues S; PluriCell Biotech, São Paulo, Brazil.
  • Gonçalves J; PluriCell Biotech, São Paulo, Brazil.
  • Góes ME; Department of Biochemistry, Institute of Chemistry, University of São Paulo, São Paulo, Brazil.
  • Alvim JM; PluriCell Biotech, São Paulo, Brazil.
  • Silva AC; Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil.
  • Lino VS; Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
  • Boccardo E; Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
  • Goulart E; Human Genome and Stem Cell Research Center, Department of Genetics and Evolutionary Biology, Institute of Biosciences, University of São Paulo, São Paulo, Brazil.
  • Pereira A; Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil.
  • Dariolli R; PluriCell Biotech, São Paulo, Brazil.
  • Valadares M; Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Biagi D; PluriCell Biotech, São Paulo, Brazil.
SAGE Open Med ; 8: 2050312120966456, 2020.
Article em En | MEDLINE | ID: mdl-33149912
OBJECTIVES: To establish a straightforward single-cell passaging cultivation method that enables high-quality maintenance of human induced pluripotent stem cells without the appearance of karyotypic abnormalities or loss of pluripotency. METHODS: Cells were kept in culture for over 50 passages, following a structured chronogram of passage and monitoring cell growth by population doubling time calculation and cell confluence. Standard procedures for human induced pluripotent stem cells monitoring as embryonic body formation, karyotyping and pluripotency markers expression were evaluated in order to assess the cellular state in long-term culture. Cells that underwent these tests were then subjected to differentiation into keratinocytes, cardiomyocytes and definitive endoderm to evaluate its differentiation capacity. RESULTS: Human induced pluripotent stem cells clones maintained its pluripotent capability as well as chromosomal integrity and were able to generate derivatives from the three germ layers at high passages by embryoid body formation and high-efficient direct differentiation into keratinocytes, cardiomyocytes and definitive endoderm. CONCLUSIONS: Our findings support the routine of human induced pluripotent stem cells single-cell passaging as a reliable procedure even after long-term cultivation, providing healthy human induced pluripotent stem cells to be used in drug discovery, toxicity, and disease modeling as well as for therapeutic approaches.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: SAGE Open Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Brasil País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: SAGE Open Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Brasil País de publicação: Reino Unido